Short communication: Effect of supplementation with Lactobacillus casei Shirota on insulin sensitivity, β-cell function, and markers of endothelial function and inflammation in subjects with metabolic syndrome—A pilot study - Tripolt, N.J.; Leber, B.; Blattl, D.; Eder, M.; Wonisch, W.; Scharnagl, H.; Stojakovic, T.; Obermayer-Pietsch, B.; Wascher, T.C.; Pieber, T.R.; Stadlbauer, V.; Sourij, H. (Journal of dairy science, 2013)
Keywords: animals; bacteria; blood; cell adhesion; Dietary Supplements; drug effects; drug therapy; endothelial function; Endothelium, Vascular; Endothelium, Vascular - drug effects; Endothelium, Vascular - physiology; fasting; Glucose Tolerance Test; glucose tolerance tests; homeostasis; Humans; inflammation; Inflammation - drug therapy; insulin resistance; Insulin Resistance - physiology; insulin secretion; insulin sensitivity; Insulin-Secreting Cells; Insulin-Secreting Cells - drug effects; Insulin-Secreting Cells - physiology; Lacticaseibacillus casei; Lactobacillus casei; Lactobacillus casei - metabolism; Lactobacillus casei Shirota; Male; metabolic syndrome; Metabolic Syndrome - drug therapy; metabolism; Middle Aged; pharmacology; physiology; Pilot Projects; probiotics; Probiotics - pharmacology; therapeutics; metabolic syndrome; endothelial function; insulin sensitivity; Lactobacillus casei Shirota